Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Hypertension 2Melanoma 1Lymphoma, Follicular 1

Interventions

relacorilant 4Hydrochlorothiazide 4Nutrition Assessment 3Labetalol 2Bevacizumab 2Angiotensin-Converting Enzyme Inhibitors 2Amlodipine 2ziprasidone 1sacubitril and valsartan sodium hydrate drug combination 1pembrolizumab 1fimasartan 1enzalutamide 1clevidipine 1cediranib 1bicalutamide 1aliskiren 1Zolpidem 1Warfarin 1Vitamin D 1Vecuronium Bromide 1Vancomycin 1Tumor Necrosis Factors 1Tranexamic Acid 1Tobramycin 1Thiazides 1Therapeutics 1Surveys and Questionnaires 1Sunitinib 1Sulindac 1Spironolactone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Hypertension × Angiotensin-Converting Enzyme Inhibitors × Clear all
NCT04334824 2024-09-19

Hydrochlorothiazide and Risk of Skin Cancer

Canadian Network for Observational Drug Effect Studies, CNODES

Completed
2,953,748 enrolled
Dermatologic

Hypertension, Melanoma

NCT01258764 2015-05-20

1HAT

Scripps Translational Science Institute

Phase NA Completed
2 enrolled
Lymphoid

Hypertension, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡